Cargando…

Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk

(1) Background: The relationship between anxiety and depression in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular (CV) risk remains uncertain. Therefore, we aimed to assess whether anxiety and depression are associated with increased CV risk in MAFLD. (2) Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismaiel, Abdulrahman, Spinu, Mihail, Leucuta, Daniel-Corneliu, Popa, Stefan-Lucian, Chis, Bogdan Augustin, Fadgyas Stanculete, Mihaela, Olinic, Dan Mircea, Dumitrascu, Dan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102968/
https://www.ncbi.nlm.nih.gov/pubmed/35566616
http://dx.doi.org/10.3390/jcm11092488
_version_ 1784707453153181696
author Ismaiel, Abdulrahman
Spinu, Mihail
Leucuta, Daniel-Corneliu
Popa, Stefan-Lucian
Chis, Bogdan Augustin
Fadgyas Stanculete, Mihaela
Olinic, Dan Mircea
Dumitrascu, Dan L.
author_facet Ismaiel, Abdulrahman
Spinu, Mihail
Leucuta, Daniel-Corneliu
Popa, Stefan-Lucian
Chis, Bogdan Augustin
Fadgyas Stanculete, Mihaela
Olinic, Dan Mircea
Dumitrascu, Dan L.
author_sort Ismaiel, Abdulrahman
collection PubMed
description (1) Background: The relationship between anxiety and depression in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular (CV) risk remains uncertain. Therefore, we aimed to assess whether anxiety and depression are associated with increased CV risk in MAFLD. (2) Methods: We conducted a cross-sectional observational study involving 77 subjects (39 MAFLD patients, 38 controls), between January and September 2020. Hepatic steatosis was assessed using a combination of hepatic ultrasonography and SteatoTest(TM). CV parameters were evaluated using echocardiography and Doppler ultrasound. Self-reported questionnaires pertaining to symptoms of anxiety and depression were used. Anxiety was evaluated using Lehrer Woolfolk Anxiety Symptom Questionnaire (LWASQ), further divided into somatic, behavioral, and cognitive factors, as well as a global score, and depression using Beck Depression Inventory (BDI). (3) Results: MAFLD patients presented significantly higher BDI scores (p-value 0.009) and LWASQ global scores (p-value 0.045) than controls. LWASQ somatic factor was significantly associated with global longitudinal strain (GLS) in linear analysis (−0.0404, p-value = 0.002), while it lost significance following multivariate analysis (−0.0166, p-value = 0.124). Although group (MAFLD vs. controls) predicted BDI, LWASQ global score, and LWASQ somatic factor in linear regression, they lost significance in multivariate analysis. Moreover, the relationship between interventricular septal wall thickness (IVSWT) and BDI, LWASQ global score, and LWASQ somatic factor was significant in linear analysis, but statistical significance disappeared after multivariate analysis. (4) Conclusions: Although MAFLD patients presented increased anxiety and depression risk in univariate analysis, this association lost significance in multivariate analysis. A significant association between GLS levels and LWASQ somatic factor, in addition to IVSWT in anxiety and depression in univariate analysis, was observed, but was lost after multivariate analysis.
format Online
Article
Text
id pubmed-9102968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91029682022-05-14 Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk Ismaiel, Abdulrahman Spinu, Mihail Leucuta, Daniel-Corneliu Popa, Stefan-Lucian Chis, Bogdan Augustin Fadgyas Stanculete, Mihaela Olinic, Dan Mircea Dumitrascu, Dan L. J Clin Med Article (1) Background: The relationship between anxiety and depression in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular (CV) risk remains uncertain. Therefore, we aimed to assess whether anxiety and depression are associated with increased CV risk in MAFLD. (2) Methods: We conducted a cross-sectional observational study involving 77 subjects (39 MAFLD patients, 38 controls), between January and September 2020. Hepatic steatosis was assessed using a combination of hepatic ultrasonography and SteatoTest(TM). CV parameters were evaluated using echocardiography and Doppler ultrasound. Self-reported questionnaires pertaining to symptoms of anxiety and depression were used. Anxiety was evaluated using Lehrer Woolfolk Anxiety Symptom Questionnaire (LWASQ), further divided into somatic, behavioral, and cognitive factors, as well as a global score, and depression using Beck Depression Inventory (BDI). (3) Results: MAFLD patients presented significantly higher BDI scores (p-value 0.009) and LWASQ global scores (p-value 0.045) than controls. LWASQ somatic factor was significantly associated with global longitudinal strain (GLS) in linear analysis (−0.0404, p-value = 0.002), while it lost significance following multivariate analysis (−0.0166, p-value = 0.124). Although group (MAFLD vs. controls) predicted BDI, LWASQ global score, and LWASQ somatic factor in linear regression, they lost significance in multivariate analysis. Moreover, the relationship between interventricular septal wall thickness (IVSWT) and BDI, LWASQ global score, and LWASQ somatic factor was significant in linear analysis, but statistical significance disappeared after multivariate analysis. (4) Conclusions: Although MAFLD patients presented increased anxiety and depression risk in univariate analysis, this association lost significance in multivariate analysis. A significant association between GLS levels and LWASQ somatic factor, in addition to IVSWT in anxiety and depression in univariate analysis, was observed, but was lost after multivariate analysis. MDPI 2022-04-28 /pmc/articles/PMC9102968/ /pubmed/35566616 http://dx.doi.org/10.3390/jcm11092488 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ismaiel, Abdulrahman
Spinu, Mihail
Leucuta, Daniel-Corneliu
Popa, Stefan-Lucian
Chis, Bogdan Augustin
Fadgyas Stanculete, Mihaela
Olinic, Dan Mircea
Dumitrascu, Dan L.
Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
title Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
title_full Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
title_fullStr Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
title_full_unstemmed Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
title_short Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
title_sort anxiety and depression in metabolic-dysfunction-associated fatty liver disease and cardiovascular risk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102968/
https://www.ncbi.nlm.nih.gov/pubmed/35566616
http://dx.doi.org/10.3390/jcm11092488
work_keys_str_mv AT ismaielabdulrahman anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT spinumihail anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT leucutadanielcorneliu anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT popastefanlucian anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT chisbogdanaugustin anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT fadgyasstanculetemihaela anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT olinicdanmircea anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk
AT dumitrascudanl anxietyanddepressioninmetabolicdysfunctionassociatedfattyliverdiseaseandcardiovascularrisk